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I11troductio11 
L'Etat Confusionnel Aigu (ECA) est très fréquent à l'hôpital général. Malgré ses conséquences majeures en 
terme de morbidité, de mortalité et d'utilisation des services de santé, il est sous-diagnostiqué et sous-traité. Dans 
le but d'améliorer sa prise en charge chez le patient adulte, des Recommandations pour la Pratique Clinique 
(RPC) couvrant les aspects de prévention, de diagnostic et de traitement ont été développées. 
Méthode 
Une recherche de littérature a d'abord identifié les RPC, les revues systématiques, les essais contrôlés 
randomisés et les études de cohorte sur l'ECA. La qualité des RPC et des revues systématiques ainsi que le 
niveau de preuve des études ont été détaillés. Un document couvrant l'ensemble de la prise en charge de l'ECA a 
été élaboré à partir des sources de meilleure qualité pour chaque sujet. 
Environ 400 recommandations ont ensuite été tirées de ce document. Elles ont été soumises à un panel 
multidisciplinaire d'experts des Hospices-CHUV. Les membres du panel ont évalué l'appropriation des 
recommandations en utilisant une approche valide et explicite. Cette approche prenait en compte tant le niveau 
de preuve des recommandations que l'expérience clinique des membres du panel. Les recommandations issues 
de ce processus ont été catégorisées du plus haut au plus bas degré de recommandation (de A à C) en tenant 
compte d'une part des niveaux de preuve, d'autre part du degré de consensus entre les experts. 
Le document complet ainsi que les recommandations ont finalement été soumis à deux experts internationaux 
reconnus dans le domaine de l'ECA. Leurs remarques ont été prises en compte dans le document définitif. Ce 
document, ainsi qu'un résumé des recommandations et un algorithme de prise en charge de l'ECA, ont été mis à 
disposition des soignants sur !'Intranet des Hospices-CHUV. 
Résultats : 
La plupart des recommandations étaient basées sur des preuves de faible niveau (1.3 % d'essais contrôlés 
randomisés et de revues systématiques; 14.3% d'essais non randomisés et 84.4 % d'études de cohorte et 
d'opinions d'experts). Une large majorité de ces recommandations (71.1 %) a toutefois été considérée comme 
appropriée par les experts. La fréquence et l'utilité du dépistage de l'ECA, le rôle de la contention physique et 
les indications à l'utilisation de benzodiazépines ont été les sujets les plus controversés au sein du panel. Les 
données de la littérahire et les résultats de la consultation du panel d'experts tendent à favoriser la prévention de 
l'ECA et sa prise en charge non pharmacologique. Par ailleurs, l'halopéridol reste le traitement de premier choix, 
le rôle des antipsychotiques atypiques étant toujours incertain. 
Discussions : 
Ces RPC sont les premières, à couvrir tous les champs de l 'ECA, de la prévention aux traitements 
pharmacologiques. Elles sont basées sur une méthodologie originale combinant les preuves existantes et une 
consultation formalisée d'experts. Cette méthodologie a permis de pallier partiellement à l'absence de preuve de 
bon niveau pour la plupart des sujets étudiés. Ce travail a par ailleurs mis en lumière de nombreux sujets 
controversés, qui devraient être la cible de prochaines recherches. 
Au niveau local, ces RPC visaient à améliorer la qualité des soins. Une étude est en cours dans deux services du 
CHUV pour évaluer l'effet de leur implantation sur les pratiques cliniques. 
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Abstract 
Objective: Delirium is highly prevalent in general hospitals but 
remains underrecognized and undertreated despite its association 
with increased morbidity, mortality, and health services utilization. 
To enhance its management, we developed guidelines covering ail 
aspects, from risk factor identification to preventive, diagnostic, 
and therapeutic interventions in adult patients. Methods: Guide-
lines, systematic reviews, randomized controlled trials (RCT), and 
cohort studies were systematically searched and evaluated. Based 
on a synthesis of retrieved high-quality documents, recommenda-
tion items were submitted to a multidisciplinary expert panel. 
Experts scored the appropriateness of recommendation items, 
using an evidence-based, explicit, multidisciplinary panel 
approach. Each recommendation was graded according to this 
process' results. Results: Rated recommendations were mostly 
supported by a low level of evidence (1.3% RCT and systematic 
reviews, 14.3% nonrandomized trials vs. 84.4% observational 
studies or expert opinions). Nevertheless, 71.1 % of recommenda-
tions were considered appropriate by the experts. Prevention of 
delirium and its nonpharmacological management should be 
fostered. Haloperidol remains the first-choice drug, whereas the 
role of atypical antipsychotics is still uncertain. Conclusions: 
While many topics addressed in these guidelines have not yet been 
adequately studied, an explicit panel and evidence-based approach 
allowed the proposai of comprehensive recommendations for the 
prevention and management of delirium in general hospitals. 
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Introduction 
Delirium is an acute change in cognition with altered 
consciousness and impaired attention that fluctuates over 
time [l]. It is a frequent condition seen in general hospitals. 
Its prevalence ranges from 11 % to 33% on admission [2-4], 
and its incidence during hospital stay ranges between 3% and 
56% [2,3,5,6]. Delirium is associated with adverse outcomes, 
including increased morbidity, increased mortality, and 
increased health services utilization [7-15]. Despite these 
observations, delirium recognition rates are low (12-43%) 
[ 4, 16-18], and its management remains inadequate in up to 
80% of patients [16]. This suggests Jack of preventive and 
screening activities, missed diagnoses, and inappropriate 
management of diagnosed delirium. Beneficial changes 
following guidelines implementation have been demonstrated 
in several domains [19]. Following the adaptation [20] and 
implementation [21] of guidelines for depression in general 
hospitals,. we unde1iook the development of new specific 
guidelines covering ail relevant aspects of the management of 
delirium among adult patients in general hospitals. 
Methods 
We chose to start with a strategy of adapting published 
guidelines, where available, in order not to perform anew 
valid high-quality work that had been previously conducted 
[22]. Thus, we first searched to identify high-quality clinical 
practice guidelines and completed our sources of information 
with systematic reviews and, in the absence of such docu-
ments, clinical trials and cohort studies, when appropriate. 
The main steps of guidelines development were: (a) a 
systematic literature search; (b) the rating of each basic 
element of recommendation (recommendation item) derived 
from the literature by a multidisciplinaiy expert panel, using 
nominal group technique [23]; (c) the incorporation of 
approved rec01runendation items in specific recommenda-
tions; and (d) a review of the final recommendations by 
international experts. This process was conducted by the first 
author, a psychiatry resident, assisted by a development team 
(senior psychiatrist and senior clinical epidemiologist), in 
collaboration with a multidisciplinaty expert panel represen-
tative of the future users of the guidelines. The panel included 
14 experts: four psychiatrists (two specialized in old age 
psychiatry), one geriatrician, one psychiatrie nurse, one 
neurologist, one intensive care clinician, one intensive care 
nurse, one general internist, one anesthetist, one orthopedic 
surgeon, one clinical epidemiologist, and one pharmacologist. 
Literature search 
The aim of this search was to identify existing guidelines 
and systematic reviews on delirium in adults and in the 
elderly. Delirium in children was beyond the scope of this 
research project. Two different search strategies were 
performed, based on a previously developed and tested 
strategy (www.chuv.ch/cepic/RPC_strat.html). Medline, 
PsychINFO, Web of Knowledge, EMBASE, and the 
Cochrane Library databases were used to identify publica-
tions in English and French from 1997 to August 2004 with 
the keywords "delirium," "confusion," "hallucination," and 
"delusion." Articles were selected through a three-step 
screening process based on reviews of the title, abstract, 
and content of the paper. Additional references from 
bibliographies were reviewed and included if considered of 
relevance. The sites of the National Guideline Clearinghouse 
(www.guideline.gov), the Guidelines International Network 
(www.g-i-n.net), the National Institute for Clinical Excel-
lence (www.nice.org.uk), the New Zealand Guidelines 
Group (www.nzgg.org.nz), the Scottish Intercollegiate 
Guidelines Network (www.sign.ac.uk), and national psychi-
atrie associations were examined. In addition, specific 
searches were developed for topics (such as risk factors for 
delirium, prevention of delirium, and physical restraints) not 
covered by recent guidelines or systematic reviews. Medline, 
PubMed, EMBASE, and the Cochrane Library were used 
without time limitations for these searches. Detailed liter-
ature search strategies are available from the authors on 
request. The literature search was updated for the submission 
of this article. It was repeated using the same methodology 
for the period from Janumy 2004 to Februmy 2006. 
Resu!ts of literature search 
Searches on guidelines identified 1550 papers, including 
519 articles in Medline, 67 articles in PsychINFO, 724 miicles 
in the Web ofKnowledge, and 240 articles in EMBASE. Four 
guidelines were identified in Medline [24-27]. No additional 
guidelines were found in PsychINFO, the Web ofKnowledge, 
or EMBASE. One additional guideline was identified on an 
Internet site [28], and another was identified through contacts 
with delirium experts [29]. Searches on systematic reviews 
identified 3178 papers, including 2099 miicles in Medline, 334 
articles in PsychINFO, 724 articles in the Web ofKnowledge, 
and 21 articles in the Cochrane Librmy. Sixteen systematic 
reviews [7,12,30-43] were found in Medline, one in the Web 
of Knowledge [44], one in EMBASE, [45] and one in the 
Cochrane Libra1y [46]. No additional systematic review was 
found in PsychINFO. One systematic review was identified on 
an Internet site [ 4 7]. Altogether, 5 guidelines and 19 systematic 
reviews were therefore identified. The results of literature 
search update are not detailed here because of space limitations 
but are available from the authors on request. No new 
guidelines were retrieved byupdating. Five systematic reviews 
were identified [48-52]. The quality of retrieved guidelines 
was evaluated with the Appraisal of Guidelines for Research 
and Evaluation instrument (www.agreetrust.org) by two 
independent raters (L.M. and R.V.). Systematic reviews were 
evaluated by the first author using the Cochrane Library 
criteria [53] and existing references [54,55]. The six most 
important domains assessed were: (a) clarity of the clinical 
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question examined; (b) quality and extent of the literature 
search; (c) inclusion criteria; (d) quality of the methodological 
evaluation of retrieved studies; (e) review method; and (f) 
meta-analysis, if present. Based on this evaluation, their results 
were considered relevant or not to drawing related recom-
mendation items. 
Development of recommendations 
The retrieved literature was synthesized by selecting, for 
each topic (i.e., prevention, risk factors, screening, diagnosis, 
and management), the most appropriate source of evidence, 
according to the quality of the study and the level of 
evidence. Based on the quality of available literature, the 
level of evidence according to the Oxford classification (see 
Table 1 and www.cebm.net/levels_of_evidence.asp) was 
determined for each recommendation item. Drafts of 
recommendation items were reviewed by and discussed with 
the expert panel. About 400 recommendation items, cover-
ing risk factors, prevention, identification, diagnoses, and 
management of delirium, were identified. In the first round, 
the appropriateness of recommendation items was rated 
separately by each member of the expert panel, using an 
adapted RAND appropriateness method [23]. The experts 
scored each recommendation item on a Likert scale ranging 
from 1 (extreme/y appropriate) to 9 (extremely inappropri-
ate ). The experts were asked to take into account in their vote 
both the result of literature synthesis (with its level of 
evidence) and their clinicat experience. Votes were aggre-
gated into four categories (appropriate, uncertain, inappro-
priate, and disagreement) according to the median vote of 
the experts and the level of intrapanel disagreement. 
Disagreement was defined as the occurrence of at least 4 of 
14 experts voting in one to three categories and at least four 
others voting in seven to nine categories. In the absence of 
disagreement, a recommendation item was classified as 
appropriate (median= 1-3), uncertain (median=4-6), or 
Table 1 
Levels of evidence and grades of recommendation 
inappropriate (median=7-9). Ali items on which disagree-
ment occurred were classified as uncertain. After analyzing 
the first round of ratings, the experts received an individu-
alized feedback document featuring their own initial rating 
and the panel median rating for each recommendation item. 
Recommendation items with disagreement were discussed 
by the experts at two additional panel meetings and were 
subsequently rated individually a second time. 
Following this process, recommendations were graded for 
each recommendation item through a rating that combined 
the level and quality of evidence, and the degree of 
appropriateness and consensus among the experts. The grade 
of recommendation was based on the level of evidence (i.e., 
Oxford classification: Level !=Grade A; Levels II and 
III=Grade B; Levels IV and V=Grade C). In the case of a 
ve1y high appropriateness rating ( defined by a median vote of 
1, i.e., extremely appropriate) and consensus among the 
experts, a superior grade of recommendation was chosen 
(e.g., Level II on the Oxford classification with ve1y high 
appropriateness rating and consensus among panelists implies 
a Grade A recommendation). Grading definitions are shown 
in Table 1. The final draft was reviewed by two international 
experts in delirium and revised according to their comments. 
The results of literature update were synthesized by the first 
author and discussed with ail authors. Sorne changes were 
introduced in the text, and relevant modifications were 
submitted to the expert panel. Changes in recommendations 
resulting from the update are mentioned in the tables. 
Presentation of guide!ines 
The guidelines consist of a full-text document and a 
summmy algorithm developed for implementation, which 
are both accessible to hospital staff through the intranet 
system of the University Hospital of Lausanne. To enhance 
readability, the present paper focuses on the most important 
recommendations, white the entire guidelines are summar-
Levels of evidence* Grades of recommendation 
Level 1 
RCT 
Systematic reviews of RCT (homogeneous) 
Systematic reviews 
Level II 
Non-randomized controlled trials 
Level III 
Prospective cohort studies 
Grade A: Based on fair evidence or on acceptable evidence with a high consensus between experts 
(Level 1 evidence, or Level II/Ill evidence with high consensus) 
Grade B: Based on acceptable evidence or on sufficient evidence with a high consensus between 
experts (Level II/Ill evidence, or Level IVN evidence with high consensus) 
Level IV Grade C: Based on acceptable evidence 
Retrospective cohort studies and case-contrai studies (Level IVN evidence with sufficient consensus between experts) 
Level V 
Case reports and published expe1t opinions 
Grade 1 (i): There is no sufficient evidence or no sufficient consensus to formulate any 
recommendation (i.e., studies or expert opinions are contradictory) 
(Note: In this case, the decision must be made by considering particular circumstances and the 
clinical experience of the practitioner.) 
* Data from the Oxford classification (www.cebm.nct/levels_oLevidence.asp). 
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ized in Tables 2-8. References could not be included in the 
current tables for publication, but the full-text document 
indicates references for every recommendation (available 
from the authors on request). 
Results 
The 392 recommendation items on delirium that were 
submitted to the expert panel resulted in about 5500 ratings 
(response rate=94%). Most recommendation items had a low 
level of evidence (Level I, 1.3%; Level II, 6.1 %; Level III, 
8.2%; Level IV, 6.6%; Level V, 77.8%). However, of the 
recommendation items, 71.1 % were considered by the 
experts as appropriate, 21. 7% were considered uncertain, 
and 7 .2% were considered inappropriate. A permanent 
disagreement remained among the experts in only 3.8% of 
propositions, which were classified into the uncertain 
recommendation. The dispersion of votes was shown to be 
related to the level of evidence, with interquartile range 
(IQR) being 1 for Level I, 4 for Level V, and between 2 and 
3 for Levels II-IV. On the other hand, this dispersion was 
similar between the experts working in the field of psychiatry 
and those practicing somatic medicine (IQR=4). The 
frequency and usefulness of screening for delirium, the role 
of physical restraints, the benefits of electroencephalogram 
(EEG) and lumbar puncture (LP), and selected indications 
for benzodiazepines in agitated delirium in younger adults 
were the most controversial topics among the panelists. 
Risk factors 
One systematic review studied risk factors for delirium 
[30]. Since this publication, 21 prospective studies have 
Table 2 
Risk factors for delirium 
General factors 
Central nervous system factors 
Metabolic factors 
Other systemic factors 
Substance-related factors 
Environmental factors 
Predisposing factors 
(on admission) Grade 
Age >70 years A 
Severity of illness A 
Cognitive impairment A 
Depression in the eldcrly B 
Sensoty impairment B 
Prcvious stroke B 
Preoperative electrolyte B 
disturbances 
Preoperative dehydration B 
Dehydration c 
Alcohol abuse B" 
Number of drugs B 
before admission 
Number of psychotropics B 
before admission 
Sensoty deprivation C" 
or ovcrload 
Plcase refer to Table 1 for grading definitions. 
Precipitating factors Aggravating 
(during stay) Grade factors Grade 
Stroke A 
Central nervous system pathological process B 
Metabolic, electrolyte, and A 
endocrine disturbances 
Fever c 
Infections A 
Pain B 
Traumatism c 
Hypoperfüsion, hypoxia, and B 
cardiac or pulmonary failure 
Organ failure c 
Drug or toxic withdrawal A 
Number of drugs and number B 
of psychotropic drugs 
Anticholinergic drugs B 
Opioids c 
B Intensive care unit B 
Physical restraints B 
High number of B 
room changes 
Absence of a clock B 
Absence of glasses B 
Patients who are older (>70 years), severely ill, or cognitively impaired are most vulnerable to delirium. They should be first targeted for the identification of 
other risk factors (B). 
Whenever possible, cognitive impairment, fever, dehydration, pain, and electrolytic disturbances should be systematically detccted using, for example, a 
checklist (B). 
New drng treatments should be introduced with caution (C). 
Any treatment change should be considered with caution, especially with regard to psychotropic drngs, anticholinergic drugs, and opioids (C). 
Pain should be adequately managed (C). 
Physical restraints shou\d be avoided (C). 
In surgical patients, postoperative perfusions and transfusions should be used cautiously (C). 
a Recommendation modified by the updating of guidelines. 
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Table 3 
Recommendations for the prevention of delirium 
General recommendations 
Detect and treat cognitive impairment 
Favor high-quality sleep 
Minimize drng side effccts 
Prevent/cotTect electrolytic 
disturbances and dehydration 
Improve communication and orientation 
Limit sens01y underload or overload 
Tnvolve and inform significant others 
Avoid malnutrition and 
vitamin dcficiencies 
Prevent or treat withdrawal 
Do not use physical restraints 
F av or mobilization 
Optimizc operativc conditions 
Consider interventions on the system 
Please refer to Table 1 for grading definitions. 
Specific recommendations 
Routine screening of cognitive fonctions and delirium, whenever 
possible, using standardized instruments (e.g., MMSE or BOMC on 
admission, and CAM during hospital stay) 
Cognitively stimulating activities adapted to the patient 
Nonphannacological sleep promotion 
Noise reduction; use of low-level lighting; avoidance of 
constant lighting 
Maintenance of a nomial sleep-wake cycle 
Limitation of the total number of drugs 
Avoidance or cautions use of the following medications: 
• Psychotropics, especially hypnosedatives and benzodiazepines 
• Anticholinergic drugs 
• Opioids 
Stimulation of adequate hydration; use of fluid balance charts 
Biochemical screening; early management of electrolyte disturbances 
Hypodermoclysis if oral intake is inadequate 
Regular verbal communication; use of short sentences; frequent 
information on place, reason for hospitalization, and daily activities; 
whenever possible, involvement of patient in the process of care; 
information and reassurance about medical procedures 
"On-time" clocks and calendars; familiar artifacts, whenever possible 
(i.e., posters); avoidance ofward or room transfers; continuity of care 
Screening for visual and hearing impairment; provision of visual and 
hearing aids; adequate lighting; use of nightlights; avoidance of blind 
rooms (without windows) 
Information of proxies regarding delirium; encouragement of visits to 
the patient and involvement in orientation; nursing and feeding; support 
of proxies 
Nutritional support and/or vitamin supplements for high-risk groups 
(i.e., B vitamins for alcoholic abusers) 
If middle-aged adults are at high risk for alcohol withdrawal, 
prevention with benzodiazepines 
Clomethiazole for prevention of withdrawal in the elderly 
Systematic screening for alcohol abuse 
Protocol for physical restraints 
Avoidance of immobilization; education regarding hazards of bcd rest 
Limiting the use of cathcter and intravenous line; avoidance of 
the use of Foley catheter 
Early mobilization protocol; cvaluation by physiotherapist, whenever 
necessaiy 
Stimulation of mobility; performance of self-care and daily activities 
Adequate analgesia; patient-controlled analgesia, if feasible 
Prevcntion of postoperative hypotension/hypoxemia 
Maintenance of postoperative hematocrit level at >30% 
Staff education 
Development and implementation of guidelines regarding harmful 
procedures (i.e., physical restraints, polymedication, unnccessaiy 
catheters) 
Adequate staff allocation 
Involvement of volunteers and family 
375 
Grade 
A 
c 
A 
A 
A 
c 
c 
A 
B 
c 
B 
B 
A 
c 
B 
A 
B 
B 
A 
A 
B 
B 
B 
B 
c 
c 
A 
B 
B 
c 
investigated this tapie [17,56-75]. In addition, one system-
atic review studied postoperative risk factors for delirium 
[76]. According to Inouye and Charpentier [59] and Inouye 
[77], risk factors were grouped into predisposing and 
precipitating factors. Predisposing factors are baseline 
conditions that increase the risk of delirium, while precip-
itating factors are triggers that cause delirium. Although this 
distinction may seem artificial, it was adopted because it 
clarifies the potential contribution of these conditions to the 
multifactorial pathway leading to delirium. This classifica-
tion also provides a framework for preventive interventions, 
one of the aims of the development of the present guide-
lines. The contribution of drugs, most often considered as 
precipitating factors, was examined by means of a specific 
literature search [59,78-82]. In one study, environmental 
factors were found to aggravate diagnosed delirium [83]. 
Table 2 summarizes the risk factors for delirium and the 
general recommendations for identification. 
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Table 4 
Standardized instruments for delirium 
Screening on admission Grade Screening during stay Grade Diagnosis 
Instrument MMSE 
Use On admission 
c 
c 
Users Medical or nursing staff C 
with adequate training 
Please refer to Table 1 for grading definitions. 
CAM/BO MC c 
Depending on the situation, C 
at least twice a week 
Medical or nursing staff 
with adequate training 
c 
CAM 
To assist in diagnosis 
Medical or nursing staff with 
adequate training 
Diagnosis may be based on DSM-!Vor ICD-10 criteria, a standardized instrument, or both (B). 
Grade Rating of severity Grade 
c DRS or MDAS c 
c To rate severity c 
c Medical or nursing staff c 
with adequate training 
Prevention 
Systematic reviews [7,31,39,47,51] and recent studies 
on delirium prevention [5,84-90] led to the examination of 
a series of potential interventions. Multicomponent inter-
vention strategies based on a specialized delirium con-
sultation team and/or specific staff training were shown to 
prevent delirium in surgical and medical inpatients 
[5,7,31,39,47,51,84-89], while pharmacological prevention 
through haloperidol was unable to lower its incidence [90]. 
Patients at risk for delirium, such as elderly persans 
(270 years), severely ill individuals, and patients with cogni-
tive impairment, should be the target of nonpharmacological 
preventive interventions (Table 3). However, only a few 
interventions are based on sound evidence, and cost concern 
is an important barrier to their implementation. 
Table 5 
Screening and diagnosis 
Screening for delirium may improve its detection, as 
suggested by several studies and previous guidelines 
[24,26,28,91]. However, only a few studies of variable 
methodological quality investigated this issue [92-94]. 
Despite this relative lack of evidence, a consensus was reached 
Histoty, physical examination, and additional investigations 
Histoty 
Status 
First-step investigations 
Investigations for selected indications 
Please refer to Table l for grading definitions. 
Full drug histo1y, including over-the-counter drugs 
Substance abuse (e.g., alcohol, rccrcational drugs, etc.) 
Prcvious delirium 
Sens01y deficits and/or aids (e.g., hearing aid, glasses, etc.) 
Histo1y by proxies 
Neurological examination 
Evidence of alcohol abuse or withdrawal 
Nutritional status 
Full blood count 
Electrolytes (sodium, potassium, and calcium) 
Rena! function (blood urea nitrogen and creatinine) 
Urine analysis 
Blood gases 
Liver function tests (alanine amino transferase, aspartate amino transferase, and bilirubin) 
Glucose 
HIV serology 
Blood levels of drugs 
Blood and urine cultures 
Urinal screening for toxics 
Vitamin B12 and folate serum levels 
Antinuclear antibodies 
Scrcening for heavy metals 
Systemic lupus 
Urinaiy porphyries 
Ammonium 
Magnesium and phosphate 
Albumin 
Alkaline phosphatase 
The identification and treatment of underlying causes is the comerstone of delirium management (B). 
Grade 
B 
B 
B 
B 
B 
B 
B 
c 
B 
B 
B 
B 
c 
c 
c 
B 
B 
B 
B 
B 
B 
c 
c 
c 
c 
Potentially involvcd drugs should be stopped early, biochemical disturbances should be corrected, and antibiotic treatment should be rapidly introduced for 
infections (B). 
History by proxies should be detem1ined to differentiate delirium from dementia and to document previous cognitive status (B). 
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Table 6 
Indications for standard EEG, brain imaging, and LP 
EEG 
Brain imaging 
LP 
Indications 
Differentiation of delirium from nonconvulsive or temporal lobe epilepsy 
Identification of encephalitis 
No cause identified in refractory and persistent delirium 
Usefulness of EEG in differentiating delirium from dementia 
Cerebral CT 
Focal neurological signs 
Development of delirium after head injmy or fall 
Patients with pathology potentially associated with intracranial processes ( e.g., metastatic cancer) 
No cause identified in refractory and persistent delirium 
Magnetic resonance imaging 
Patients with pathology potentially associated with intracranial processes (e.g., rnetastatic cancer) 
Other indications" 
Meningism and fever and/or headache 
Meningism only 
If headache and meningism only, or if no cause is identified in refractory and persistent delirium" 
Please refer to Table 1 for grading definitions. 
" In these indications, the usefulness of magnetic resonance imaging and LP is uncertain and should be appreciated by a specialist. 
377 
Grade 
c 
c 
c 
c 
c 
c 
c 
c 
I 
A 
B 
to recommend systematic screening for delirium in at-risk 
patients. Screening should be conducted with standardized 
validated tools [37]. Instrnments identifying cognitive impair-
ment, such as the Mini-Mental State Exam (MMSE) [95] and 
the Blessed Orientation-Memory-Concentration (BOMC) 
[96,97], show the best clinimetric properties for delirium 
screening (Table 4). Moreover, the MMSE proved to be helpful 
in monitoring the development and resolution of delirium in 
geriatr·ic patients [98]. The gold standards for diagnosing 
delirium are the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV) or International Classi-
fication of Diseases, Tenth Revision (ICD-I 0) criteria, but their 
Table 7 
Pharmacological treatment 
Indications for drug treatment 
Type of drugs 
Indications for atypical antipsychotics 
Combinations with benzodiazepine 
Please refer to Table 1 for grading definitions. 
Recornrncndations 
Avoidance of systemic pharmacological treatment 
Uncontrollable agitation despite nonphannacological interventions 
Danger to the patient, staff, or others 
Anxiety in agitated or hallucinating patients 
Need to control agitation, to perform an investigation, or to provide treatment 
Uncertain indication 
Hypoactive delirium 
Haloperidol 
Risperidone" 
Quetiapine" 
Clomethiazole 
Clozapine" 
Olanzapine'"b 
Bencfit of chlorpromazine uncertain 
Contraindication to classical antipsychotics 
Side effects of classical antipsychotics 
No benzodiazepine in the clderly (>70 years) 
Indications in younger adults 
Uncontrollable agitation while on antipsychotic treatment 
Caution required given the potential side effects of these substances in delirium 
Uncertain indications 
Lack of response to antipsychotic treatment 
Tolerance to only low doses of antipsychotics 
Grade 
B 
B 
B 
B 
c 
B 
c 
c 
c 
c 
c 
I 
c 
c 
c 
c 
c 
Electrocardiogram of patients treated with antipsychotics should be monitorcd to detect QT interval prolongation (risk of "torsade de pointes") (B). 
Benzodiazepines as monotherapy are reserved for delirium caused by alcohol or benzodiazepine withdrawal as single cause. Whenever another cause is 
suspected, a combination of haloperidol and benzodiazepines should be used (B). 
Vitamin supplements should be instituted in patients with possible B-vitamin deficiencies (i.e., alcohol abuser or malnourished) (B). 
Sedation may be indicated in end-of-life care (B). 
Cholinergies, such as physostigmine, may be useful in delirium caused by anticholinergic rnedications (I). 
a Clinicians should pay attention to possible cerebrovascular events induced by these medications in the elderly. 
b Recommendation modified by the updating of guidelines. 
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Table 8 
Other recommendations 
Recommendations Grade 
Dangerous patients Physical restraint is an exceptional measure that may be indicated if c 
• Other less restrictive means have failed and 
• The patient's behavior puts self and/or staff and/or others at risk 
Restraints should be used only after discussion with the patient, proxies 
(including those with durable power of attorney), and nursing staff. The use of a 
restraint protocol is mandatory to monitor evolution over titne. Reevaluation 
of restraint use should occur periodically, as frequently as every 15 min in the acute phase. 
Specialized refe1rnl Referral to a specialist (psychiatrist, old age psychiatrist, geriahician, neurologist, etc.) may be required if; C 
• Delirium is unresponsive to trcatment 
• There is important agitation with possible need for physical restraint 
• There are doubts about management 
lnfonned consent lnfonned consent should not be signed by a delirious patients as one's competency is altered C 
Please refer to Table 1 for grading definitions. 
externat validity does not seem satisfying [99]. ICD-10 criteria 
are considered more specific but less sensitive than DSM-IV 
criteria [ 1OO,101], but both classifications identify conditions 
that seem to share a similar prognosis [! 02]. Other instruments 
may also be useful in diagnosing delirium [ 103]. Among them, 
the Confusion Assessment Method (CAM) has been validated 
and extensively studied [ 104], and a special version for use in 
the intensive care unit (Confusion Assessment Method for the 
Intensive Care Unit) is available [105]. The Delirium Rating 
Scale (DRS) [ 106, 107] or the Memorial Delirium Assessment 
Scale (MDAS) [108] may be useful in rating the severity of 
delirium. Table 4 smrunarizes recommended instrnments and 
their proposed use. 
Investigation and treatment 
The management of delirium includes: (a) the identi-
fication and treatment of ail potential underlying causes 
(precipitating factors); (b) the provision of supportive care; 
and (c) the selection of appropriate phannacological treat-
ment for behavioral symptoms, when necessary. The 
identification and treatment of underlying causes is the 
cornerstone of delirium management. Medical history 
should be gathered from patients and proxies, and physical 
examination should be conducted in every patient 
[7,24,26,91,109,110]. Depending on information and clin-
ical examination, additional investigations may be consid-
ered. Sorne investigations are recommended for evety 
patient, while others are proposed in selected indications 
(Table 5). The utility of EEG, LP, and brain imaging (CT/ 
MRI) is a much debated topic in the literature and has also 
been a subject of controversy in the expert panel (Table 6). 
Suppotiive care interventions include ail preventive inter-
ventions listed in Table 2 [ 5, 111-113]; their aim is to 
restore physiological conditions and to reorient the patient. 
These interventions should be considered for ail delirious 
patients. Specific therapeutic interventions and nurse-
directed care seem to have a beneficial effect on the 
evolution of delirium in surgical [7,44,47] and medical 
[5,51,88,89,114] inpatients. 
Sound evidence supporting specific indications for drng 
treatment in delirium is still lacking (Table 7) [52]. A 
consensus to avoid systemic drng treatment of delirious 
patients was reached by the experts. When phannacological 
treatment seems appropriate, antipsychotics are considered 
first-choice medications. Haloperidol has been shown to be 
efficient in treating symptoms of delirium [ 115] and to have a 
positive effect on the severity and duration of delirium [90]. 
For safety reasons, an electrocardiogram should be obtained 
as soon as feasible (risk of QT interval prolongation and 
arrhythmia) [ 116, 117]. The usefulness of new atypical 
antipsychotics has been debated in the literature. Sorne 
evidence indicate that olanzapine [ 118-121] and quetiapine 
[122] have efficacy similar to that ofhaloperidol, with fewer 
side effects, in delirious patients; risperidone showed similar 
efficacy and side effects [123]. Numerous authors advocate 
that results from trials in dementia patients suffering from 
behavioral and psychological symptoms allow the recom-
mendation of new atypical antipsychotics in delirium. These 
drugs have been associated with a potential increased risk of 
cerebrovascular events and mortality in dementia patients 
[124, 125], leading the Food and Drug Administration to 
issue a warning advising avoidance of their use for this 
indication (www.fda.gov/cder/drug/infopage/antipsychotics/ 
default.htm). However, the results of numerous randomized 
controlled trials (RCT) on this subject were recently studied 
by high-quality systematic reviews [48-50], yielding no 
definitive answer on this potential risk. Moreover, an 
additional retrospective study showed a higher risk of death 
associated with the use of conventional versus atypical 
antipsychotics [ 126]. Given these conflicting data and 
considering the fact that the studied population included 
patients with dementia rather than patients with delirium, 
haloperidol was considered to be the preferred pharmaco-
logical treatment for delirium. Taking into account that 
several atypical antipsychotics have also been rep01ied to 
cause delirium, probably because of their anticholinergic 
effect [127-129], they were recommended with a lower 
grade of recommendation. New data available in the future 
might affect this specific recommendation. Benzodiazepines 
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are not as efficient as antipsychotics and may even 
precipitate confusion [78-80,130]. They are only recom-
mended as first-choice drugs for alcohol-related or benzo-
diazepine-related withdrawal [ 131]. Following the American 
Psychiatrie Association guidelines, young patients who 
tolerate only minimal doses of antipsychotics could benefit 
from a combination of benzodiazepines and antipsychotics 
[91]. Cholinergies [114,132, 133], mianserine [ 134], ondan-
setron [135], and melatonin [ 136] have also been studied and 
could be useful in some situations, while donepezil seems to 
have no beneficial effect [137]. Clomethiazole is advocated 
by some authors [138,139] and recommended as a second-
line treatment by the experts, based on their positive clinicat 
experience. The pharmacological treatment of delirium is 
summarized in Table 7. Recommendations for the manage-
ment of dangerous patients, referral for specialized con-
sultation, and issues concerning informed consent are 
presented in Table 8. 
Discussion 
The development and implementation of guidelines is an 
important preliminmy step to improve delirium manage-
ment, given its high occurrence in patients hospitalized in 
general hospitals and highly variable care practices. A 
recent survey showed that only two countries in Europe 
possess a guideline for the diagnosis and treatment of 
delirium [ 140]. The present guidelines th us constitute a 
significant contribution from several perspectives. First, 
from a methodological standpoint, these guidelines are 
important because they were developed using rigorous 
methodology based on an extensive literature review and 
appraisal that included a formai evaluation of existing 
guidelines and covered ail aspects of delirium management. 
This methodology also included formai consultation with an 
expert panel of diverse professional and specialty back-
grounds that completed a structured appropriateness rating 
by means of nominal group technique, which is especially 
well-suited for areas of uncertainty. The guidelines were 
finally reviewed by international expe1is, and the literature 
update conducted just before submission confirmed most 
recommendations. Second, this work is also important 
because, to our knowledge, these guidelines are the first to 
caver, in English, the entire spectrum of delirium manage-
ment in general hospitals: risk factors identification, 
preventive and diagnostic strategies, and pharmacological 
and nonphannacological treatments. Finally, another con-
tribution of this work is to identify several tapies that need 
to be investigated in future research, such as the usefulness 
of systematic screening in different populations, the 
effectiveness of nonpharmacological management, and the 
place of drugs of anecdotic use (i.e., cholinergies). 
Despite the rigorous methodology used, some areas 
remain with uncertainty, and several key recommendations 
deserve further comments. First, there exists consensus 
among the expe1is to emphasize the prevention of delirium. 
Emerging data supp01i this strategy, and efforts should be 
made to implement prevention programs in at-risk popula-
tions in general hospitals. Second, atypical antipsychotics, 
which have been increasingly used over the past years and 
have been supported by some empirical evidence, were not 
recommended as first-choice drugs mainly because ofrecent 
data on cerebrovascular adverse events in the elderly. This 
position might be modified once additional data are 
available. Third, pharmacological treatment is not system-
atically recommended to treat delirious patients. Consensus 
was reached about when and under which circumstances 
pharmacological treatment is appropriate; that is, in sit-
uations where the patient's condition (e.g., agitation) 
prevents adequate care (e.g., pulling out a central intra-
venous line) or puts the patient or the nursing staff at risk 
(e.g., physical aggressiveness). 
Severa! difficulties were encountered while developing 
these guidelines. First, only a few and incomplete guide-
lines on delirium existed. A simple adaptation of previous 
high-quality guidelines was therefore considered not 
adequate, and the literature search was extended to 
systematic reviews, RCT, and cohort studies. Levels of 
evidence were frequently not specified in the guidelines 
and had to be evaluated from source studies. Finally, most 
of the tapies discussed in these guidelines had not been 
adequately studied. Therefore, only low levels of evidence 
appeared in the literature, and diverging strategies were 
recommended by different authors. To overcome these 
difficulties, the multidisciplinmy panel approach allowed an 
explicit and systematic examination of proposed recom-
mendation items, which were developed based on existing 
evidence. This strategy, combining evidence-based knowl-
edge and the consultation of an expert panel, is increasingly 
being used in the field of psychiatiy [141] and somatic 
medicine [142]. Our literature search retrieved a high 
prop01iion of low levels of evidence, thus highlighting the 
benefits of the experts' consultation. Moreover, the 
consultation triggered discussions of tapies on which 
diverging expert opinions were found in the literature. 
During the formalized meetings and voting process, 
recommendation items often had to be clarified within the 
expert panel. This certainly improved the quality of our 
guidelines, but involved heavy logistic supp01i and strong 
commitment from ail the expe1is. 
These guidelines will be implemented in several wards at 
our university general hospital, and their ability to change 
practice will be evaluated. A recent review on adherence to 
mental health guidelines showed that interventions such as 
academic detailing (visiting ofpractitioners by colleagues or 
specially trained staff to present and discuss guidelines ), 
continuons quality improvement, or feedback may not be 
sufficient to change practice [143]. Additional clinical 
resources and redesigning of the system seem to be 
necessary to improve practice, according to current evidence 
on guidelines implementation [ 19]. Moreover, changes tend 
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to return to preintervention level after the cessation of 
intervention. Recent interventions to improve the manage-
ment of delirium highlighted the need to enhance guidelines 
[144] or educational package [145] implementation by 
follow-up and teaching sessions. We intend to take into 
account our previous experiences on the implementation of 
guidelines on depression in general hospitals [21] and the 
results of the abovementioned studies when implementing 
these guidelines on delirium. 
In conclusion, the development of these guidelines 
required an extensive literature search and a formalized 
multidisciplinary expert panel approach to achieve con-
sensus on tapies not yet adequately investigated by research. 
Major efforts will be needed to implement these guidelines 
in clinical practice, to enhance the application of evidence-
based recommendations, and, thus, to improve patient care. 
Initiatives such as those from the Cochrane Libraty's recent 
protocols [ 146-148] and additional clinical research are 
mandatoty to help improve the quality and the evidence 
base of such guidelines. 
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